JPRN-jRCT2053210023招募中2 期
A Phase 2 Study of ADR-001 in Patients with Severe Pneumonia caused by SARS-CoV-2 infection (COVID-19)
Okawa Sumito0 个研究点目标入组 20 人开始时间: 2021年5月11日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •SARS-CoV-2 infection is confirmed on antigen test or PCR test
- •-Pulmonary infiltrative shadow is confirmed on chest X-ray test
- •-Just after mechanical ventilation support start (equal to it would be possible to administer an Investigational Product to a subject within 72h from the mechanical ventilation support start)
- •-PaO2/FiO2 <=200mmHg at the time of screening
排除标准
- •-Continue Pneumonia before SARS-CoV-2 infection
- •-SOFA score >= 15
- •-Infection type on DIC diagnosis criteria >= 4
- •-Deep Venous Thrombosis
研究者
相似试验
进行中（未招募）
2 期
ADR-001-N1Compensated liver cirrhosis (Child-Pugh A)JPRN-jRCT2033210425Terai Shuji9
已完成
1 期
An Exploratory Study of ADR-001 in Patients with Severe Pneumonia caused by SARS-CoV-2 infection (COVID-19)Patients with Severe Pneumonia caused by SARS-CoV-2 infectionJPRN-jRCT1080225320ROHTO PHARMACEUTICAL CO., LTD.6
招募中
1 期
ADR-04JPRN-jRCT2073220005furukawa kojiro6
已完成
2 期
DP13 * A Phase II Study in Patients with Primary Aldosteronism to Evaluate the Efficacy, Safety and Tolerability of the Aldosterone Synthase Inhibitor, DP13, over an 8-week Treatment PeriodHormonal diseasesPrimary AldosteronismNL-OMON54894DAMIAN Pharma AG15
进行中（未招募）
不适用
Phase II Study of Single Agent RAD001 in Patients with Colon Cancer and Activating Mutations in the PI3KCA gene.Colon CancerEUCTR2005-005738-11-ESnidad integral de investigación en oncologia37